prolyl-glycyl-proline and Pneumonia--Pneumococcal

Bioactive matrix fragments (matrikines) have been identified in a myriad of disorders, but their impact on the evolution of airway inflammation has not been demonstrated. We recently described a pathway where the matrikine and neutrophil chemoattractant proline-glycine-proline (PGP) could be degraded by the enzyme leukotriene A4 hydrolase (LTA4H). LTA4H classically functions in the generation of pro-inflammatory leukotriene B4, thus LTA4H exhibits opposing pro- and anti-inflammatory activities. The physiological significance of this secondary anti-inflammatory activity remains unknown. Here we show, using readily resolving pulmonary inflammation models, that loss of this secondary activity leads to more pronounced and sustained inflammation and illness owing to PGP accumulation. PGP elicits an exacerbated neutrophilic inflammation and protease imbalance that further degrades the extracellular matrix, generating fragments that perpetuate inflammation. This highlights a critical role for the secondary anti-inflammatory activity of LTA4H and thus has consequences for the generation of global LTA4H inhibitors currently being developed.

Topics: Animals; Epoxide Hydrolases; Extracellular Matrix; Flow Cytometry; Haemophilus Infections; Haemophilus influenzae type b; Inflammation; Leukocyte Elastase; Leukotriene B4; Lung; Macrophages, Alveolar; Matrix Metalloproteinase 12; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Neutrophils; Oligopeptides; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Proline; Receptors, Leukotriene B4; Streptococcus pneumoniae